Vancomycin and Blind - a phase IV clinical study of FDA data

Summary:

Blind is reported as a side effect among people who take Vancomycin (vancomycin), especially for people who are female, 60+ old, also take Ceftazidime, and have Cellulitis.

The phase IV clinical study analyzes which people have Blind when taking Vancomycin. It is created by eHealthMe based on reports of 17,160 people who have side effects when taking Vancomycin from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Blind?

Blind is found to be associated with 2,330 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Blind.

On Jun, 18, 2026

17,160 people reported to have side effects when taking Vancomycin.
Among them, 23 people (0.13%) have Blind.

Among these 23 people:

What is the gender of people who have Blind when taking Vancomycin? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Blind when taking Vancomycin? *

What are other drugs people take besides Vancomycin? *

What are other side effects people have besides Blind? *

Endophthalmitis (inflammation of the internal coats of the eye): 8 people, 34.78%
Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 4 people, 17.39%
Eye Pain: 3 people, 13.04%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.70%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 8.70%
Stress And Anxiety: 2 people, 8.70%
Pain: 2 people, 8.70%
Gait Disturbance: 2 people, 8.70%
Fever: 2 people, 8.70%
Visual Impairment: 2 people, 8.70%

What are the existing conditions these people have? *

Cellulitis (infection under the skin): 4 people, 17.39%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 13.04%
Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 8.70%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 8.70%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 4.35%
Infection: 1 person, 4.35%
Cellulitis Orbital (acute spread of infection into the eye socket): 1 person, 4.35%
Diabetes: 1 person, 4.35%
Drug Resistance (reduction in effectiveness of a drug): 1 person, 4.35%
Endophthalmitis (inflammation of the internal coats of the eye): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and have Blind?

- Check whether Blind is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin:

Vancomycin (17,165 reports)

Blind treatments and more:

Blind (45,948 reports)

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blind:

Blind (2,330 drugs)

Browse all the conditions that are associated with Blind:

Blind (1,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin (the active ingredients of Vancomycin) and Vancomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.